PRESS RELEASE published on 01/16/2026 at 00:00, 4 months 21 days ago LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies LIR Life Sciences Corp. announces a controlled comparative animal study to evaluate needle-free transdermal delivery of GLP/GIP-based obesity therapies. Study aims to advance transdermal platform and simplify treatment for obesity Lir Life Sciences Corp. Obesity Therapies GLP/GIP-based Controlled Study Needle-free Transdermal Delivery
BRIEF published on 01/09/2026 at 00:05, 4 months 28 days ago LIR Life Sciences collabore avec Neuland Labs au développement de peptides LIR Sciences De La Vie Laboratoires Neuland Peptides Pénétrant Dans Les Cellules Plateforme Transdermique Collaboration En R&D
BRIEF published on 01/09/2026 at 00:05, 4 months 28 days ago LIR Life Sciences Collaborates with Neuland Labs on Peptide Development R&D Collaboration LIR Life Sciences Neuland Laboratories Cell Penetrating Peptides Transdermal Platform
PRESS RELEASE published on 01/09/2026 at 00:00, 4 months 28 days ago LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform LIR Life Sciences Corp. enters R&D Agreement with Neuland Labs for peptide formulations. Neuland Labs to provide services for preclinical evaluation and future collaboration Lir Life Sciences Corp. Neuland Labs R&D Agreement Peptide Formulations Preclinical Evaluation
BRIEF published on 12/19/2025 at 00:05, 5 months 18 days ago LIR Life Sciences nomme le Dr Peter Singer au poste de conseiller scientifique Innovation En Santé Traitement De L'obésité LIR Sciences De La Vie Peter Singer Conseiller Scientifique
BRIEF published on 12/19/2025 at 00:05, 5 months 18 days ago LIR Life Sciences Appoints Dr. Peter Singer as Scientific Advisor Obesity Treatment Health Innovation LIR Life Sciences Scientific Advisor Peter Singer
PRESS RELEASE published on 12/19/2025 at 00:00, 5 months 18 days ago LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor LIR Life Sciences Corp. announces Dr. Peter Singer, former WHO advisor, as Scientific Advisor. Focus on global obesity treatments & market making services Market Making Services Lir Life Sciences Corp. Obesity Treatments Scientific Advisor Dr. Peter Singer
BRIEF published on 12/12/2025 at 00:05, 5 months 25 days ago LIR Life Sciences développe des traitements contre l'obésité sans aiguilles Traitement De L'obésité Brevet Provisoire Accouchement Sans Aiguille Thérapies GLP/GIP LIR Sciences De La Vie
BRIEF published on 12/12/2025 at 00:05, 5 months 25 days ago LIR Life Sciences Pursues Needle-Free Obesity Therapy Delivery Obesity Treatment Provisional Patent Needle-free Delivery GLP/GIP Therapies LIR Life Sciences
PRESS RELEASE published on 12/12/2025 at 00:00, 5 months 25 days ago LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies LIR Life Sciences files provisional patent for needle-free delivery platform for GLP/GIP therapies in obesity and metabolic diseases, aiming to improve treatment accessibility and adherence Metabolic Diseases Obesity Provisional Patent GLP/GIP Therapies LIR Life Sciences
Published on 06/06/2026 at 04:45, 21 minutes ago Battery X Metals Announces Closing of First Tranche of Private Placement to Advance Corporate Growth
Published on 06/06/2026 at 00:00, 5 hours 6 minutes ago Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
Published on 06/05/2026 at 17:00, 12 hours 6 minutes ago Silver Spruce Resources Inc. Provides an Update on the Jackie Project Acquisition
Published on 06/05/2026 at 15:00, 14 hours 6 minutes ago Norsemont Drills 20 Meters of 1.20 G/T Gold Equivalent at Bottom of Hole
Published on 06/05/2026 at 13:30, 15 hours 36 minutes ago CANEX Announces Gold Basin Resources Shareholders Approve Merger Arrangement With CANEX With 75.82% Support
Published on 06/06/2026 at 00:20, 4 hours 45 minutes ago Guild Wars 3, Modern Evolution of the MMORPG, Announced at Summer Game Fest for PC and PlayStation 5
Published on 06/05/2026 at 23:05, 6 hours ago Quantinuum Announces Closing of Upsized Initial Public Offering
Published on 06/05/2026 at 19:06, 9 hours 59 minutes ago EQS-Adhoc: Brockhaus Technologies AG: The Company's Management Board intends to return approx. €180 million of the proceeds from the sale of the Bikeleasing Group to shareholders
Published on 06/05/2026 at 18:48, 10 hours 17 minutes ago Digital transformation journey takes centre stage at ANGOTIC 2026
Published on 06/05/2026 at 18:32, 10 hours 33 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/05/2026 at 19:00, 10 hours 6 minutes ago ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 06/05/2026 at 19:00, 10 hours 6 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 06/05/2026 at 19:00, 10 hours 6 minutes ago ALTAREIT - Descriptif du programme de rachat d'actions autorisé par l'assemblée générale mixte du 4 juin 2026 et mis en œuvre par la Gérance
Published on 06/05/2026 at 19:00, 10 hours 6 minutes ago ALTAREA : Descriptif du programme de rachat d'actions autorisé par l'assemblée générale mixte du 4 juin 2026 et mis en œuvre par la Gérance
Published on 06/05/2026 at 19:00, 10 hours 6 minutes ago ALTAREIT - DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES MAI 2026